Global Radiopharmaceutical Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Radiopharmaceutical segment by Company
1. To analyze and research the global Radiopharmaceutical status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Radiopharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Radiopharmaceutical significant trends, drivers, influence factors in global and regions.
6. To analyze Radiopharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radiopharmaceutical market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiopharmaceutical industry.
Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Radiopharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Radiopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Radiopharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Radiopharmaceutical segment by Company
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Radiopharmaceutical status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Radiopharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Radiopharmaceutical significant trends, drivers, influence factors in global and regions.
6. To analyze Radiopharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Radiopharmaceutical market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiopharmaceutical industry.
Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Radiopharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Radiopharmaceutical Sales Value (2019-2030)
1.2.2 Global Radiopharmaceutical Sales Volume (2019-2030)
1.2.3 Global Radiopharmaceutical Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 RADIOPHARMACEUTICAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 RADIOPHARMACEUTICAL MARKET BY COMPANY
3.1 Global Radiopharmaceutical Company Revenue Ranking in 2023
3.2 Global Radiopharmaceutical Revenue by Company (2019-2024)
3.3 Global Radiopharmaceutical Sales Volume by Company (2019-2024)
3.4 Global Radiopharmaceutical Average Price by Company (2019-2024)
3.5 Global Radiopharmaceutical Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Radiopharmaceutical Company Manufacturing Base & Headquarters
3.7 Global Radiopharmaceutical Company, Product Type & Application
3.8 Global Radiopharmaceutical Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Radiopharmaceutical Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL MARKET BY TYPE
4.1 Radiopharmaceutical Type Introduction
4.1.1 Actinium-225
4.1.2 Lutetium-177
4.1.3 Radium-223
4.1.4 Holmium-166
4.1.5 Other
4.2 Global Radiopharmaceutical Sales Volume by Type
4.2.1 Global Radiopharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Radiopharmaceutical Sales Volume by Type (2019-2030)
4.2.3 Global Radiopharmaceutical Sales Volume Share by Type (2019-2030)
4.3 Global Radiopharmaceutical Sales Value by Type
4.3.1 Global Radiopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Radiopharmaceutical Sales Value by Type (2019-2030)
4.3.3 Global Radiopharmaceutical Sales Value Share by Type (2019-2030)
5 RADIOPHARMACEUTICAL MARKET BY APPLICATION
5.1 Radiopharmaceutical Application Introduction
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Radiopharmaceutical Sales Volume by Application
5.2.1 Global Radiopharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Radiopharmaceutical Sales Volume by Application (2019-2030)
5.2.3 Global Radiopharmaceutical Sales Volume Share by Application (2019-2030)
5.3 Global Radiopharmaceutical Sales Value by Application
5.3.1 Global Radiopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Radiopharmaceutical Sales Value by Application (2019-2030)
5.3.3 Global Radiopharmaceutical Sales Value Share by Application (2019-2030)
6 RADIOPHARMACEUTICAL MARKET BY REGION
6.1 Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Radiopharmaceutical Sales by Region (2019-2030)
6.2.1 Global Radiopharmaceutical Sales by Region: 2019-2024
6.2.2 Global Radiopharmaceutical Sales by Region (2025-2030)
6.3 Global Radiopharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Radiopharmaceutical Sales Value by Region (2019-2030)
6.4.1 Global Radiopharmaceutical Sales Value by Region: 2019-2024
6.4.2 Global Radiopharmaceutical Sales Value by Region (2025-2030)
6.5 Global Radiopharmaceutical Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Radiopharmaceutical Sales Value (2019-2030)
6.6.2 North America Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Radiopharmaceutical Sales Value (2019-2030)
6.7.2 Europe Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Radiopharmaceutical Sales Value (2019-2030)
6.8.2 Asia-Pacific Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Radiopharmaceutical Sales Value (2019-2030)
6.9.2 Latin America Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Radiopharmaceutical Sales Value (2019-2030)
6.10.2 Middle East & Africa Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
7 RADIOPHARMACEUTICAL MARKET BY COUNTRY
7.1 Global Radiopharmaceutical Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Radiopharmaceutical Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Radiopharmaceutical Sales by Country (2019-2030)
7.3.1 Global Radiopharmaceutical Sales by Country (2019-2024)
7.3.2 Global Radiopharmaceutical Sales by Country (2025-2030)
7.4 Global Radiopharmaceutical Sales Value by Country (2019-2030)
7.4.1 Global Radiopharmaceutical Sales Value by Country (2019-2024)
7.4.2 Global Radiopharmaceutical Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.5.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.6.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.7.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.8.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.9.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.10.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.11.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.12.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.13.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.14.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.15.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.16.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.17.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.18.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.19.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.20.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.21.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.22.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.23.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Bracco Imaging
8.1.1 Bracco Imaging Comapny Information
8.1.2 Bracco Imaging Business Overview
8.1.3 Bracco Imaging Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
8.1.5 Bracco Imaging Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.2.4 Bayer Radiopharmaceutical Product Portfolio
8.2.5 Bayer Recent Developments
8.3 Mallinckrodt
8.3.1 Mallinckrodt Comapny Information
8.3.2 Mallinckrodt Business Overview
8.3.3 Mallinckrodt Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
8.3.5 Mallinckrodt Recent Developments
8.4 Nordion
8.4.1 Nordion Comapny Information
8.4.2 Nordion Business Overview
8.4.3 Nordion Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.4.4 Nordion Radiopharmaceutical Product Portfolio
8.4.5 Nordion Recent Developments
8.5 Triad Isotopes
8.5.1 Triad Isotopes Comapny Information
8.5.2 Triad Isotopes Business Overview
8.5.3 Triad Isotopes Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
8.5.5 Triad Isotopes Recent Developments
8.6 Lantheus
8.6.1 Lantheus Comapny Information
8.6.2 Lantheus Business Overview
8.6.3 Lantheus Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.6.4 Lantheus Radiopharmaceutical Product Portfolio
8.6.5 Lantheus Recent Developments
8.7 IBA Group
8.7.1 IBA Group Comapny Information
8.7.2 IBA Group Business Overview
8.7.3 IBA Group Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.7.4 IBA Group Radiopharmaceutical Product Portfolio
8.7.5 IBA Group Recent Developments
8.8 GE Healthcare
8.8.1 GE Healthcare Comapny Information
8.8.2 GE Healthcare Business Overview
8.8.3 GE Healthcare Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
8.8.5 GE Healthcare Recent Developments
8.9 China Isotope & Radiation
8.9.1 China Isotope & Radiation Comapny Information
8.9.2 China Isotope & Radiation Business Overview
8.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
8.9.5 China Isotope & Radiation Recent Developments
8.10 Jubilant Pharma
8.10.1 Jubilant Pharma Comapny Information
8.10.2 Jubilant Pharma Business Overview
8.10.3 Jubilant Pharma Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
8.10.5 Jubilant Pharma Recent Developments
8.11 Eli Lilly
8.11.1 Eli Lilly Comapny Information
8.11.2 Eli Lilly Business Overview
8.11.3 Eli Lilly Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
8.11.5 Eli Lilly Recent Developments
8.12 Advanced Accelerator Applications
8.12.1 Advanced Accelerator Applications Comapny Information
8.12.2 Advanced Accelerator Applications Business Overview
8.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
8.12.5 Advanced Accelerator Applications Recent Developments
8.13 SIEMENS
8.13.1 SIEMENS Comapny Information
8.13.2 SIEMENS Business Overview
8.13.3 SIEMENS Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.13.4 SIEMENS Radiopharmaceutical Product Portfolio
8.13.5 SIEMENS Recent Developments
8.14 Dongcheng
8.14.1 Dongcheng Comapny Information
8.14.2 Dongcheng Business Overview
8.14.3 Dongcheng Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.14.4 Dongcheng Radiopharmaceutical Product Portfolio
8.14.5 Dongcheng Recent Developments
8.15 Navidea
8.15.1 Navidea Comapny Information
8.15.2 Navidea Business Overview
8.15.3 Navidea Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.15.4 Navidea Radiopharmaceutical Product Portfolio
8.15.5 Navidea Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Radiopharmaceutical Value Chain Analysis
9.1.1 Radiopharmaceutical Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Radiopharmaceutical Sales Mode & Process
9.2 Radiopharmaceutical Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Radiopharmaceutical Distributors
9.2.3 Radiopharmaceutical Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Radiopharmaceutical Sales Value (2019-2030)
1.2.2 Global Radiopharmaceutical Sales Volume (2019-2030)
1.2.3 Global Radiopharmaceutical Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 RADIOPHARMACEUTICAL MARKET DYNAMICS
2.1 Radiopharmaceutical Industry Trends
2.2 Radiopharmaceutical Industry Drivers
2.3 Radiopharmaceutical Industry Opportunities and Challenges
2.4 Radiopharmaceutical Industry Restraints
3 RADIOPHARMACEUTICAL MARKET BY COMPANY
3.1 Global Radiopharmaceutical Company Revenue Ranking in 2023
3.2 Global Radiopharmaceutical Revenue by Company (2019-2024)
3.3 Global Radiopharmaceutical Sales Volume by Company (2019-2024)
3.4 Global Radiopharmaceutical Average Price by Company (2019-2024)
3.5 Global Radiopharmaceutical Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Radiopharmaceutical Company Manufacturing Base & Headquarters
3.7 Global Radiopharmaceutical Company, Product Type & Application
3.8 Global Radiopharmaceutical Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Radiopharmaceutical Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Radiopharmaceutical Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL MARKET BY TYPE
4.1 Radiopharmaceutical Type Introduction
4.1.1 Actinium-225
4.1.2 Lutetium-177
4.1.3 Radium-223
4.1.4 Holmium-166
4.1.5 Other
4.2 Global Radiopharmaceutical Sales Volume by Type
4.2.1 Global Radiopharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Radiopharmaceutical Sales Volume by Type (2019-2030)
4.2.3 Global Radiopharmaceutical Sales Volume Share by Type (2019-2030)
4.3 Global Radiopharmaceutical Sales Value by Type
4.3.1 Global Radiopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Radiopharmaceutical Sales Value by Type (2019-2030)
4.3.3 Global Radiopharmaceutical Sales Value Share by Type (2019-2030)
5 RADIOPHARMACEUTICAL MARKET BY APPLICATION
5.1 Radiopharmaceutical Application Introduction
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Radiopharmaceutical Sales Volume by Application
5.2.1 Global Radiopharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Radiopharmaceutical Sales Volume by Application (2019-2030)
5.2.3 Global Radiopharmaceutical Sales Volume Share by Application (2019-2030)
5.3 Global Radiopharmaceutical Sales Value by Application
5.3.1 Global Radiopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Radiopharmaceutical Sales Value by Application (2019-2030)
5.3.3 Global Radiopharmaceutical Sales Value Share by Application (2019-2030)
6 RADIOPHARMACEUTICAL MARKET BY REGION
6.1 Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Radiopharmaceutical Sales by Region (2019-2030)
6.2.1 Global Radiopharmaceutical Sales by Region: 2019-2024
6.2.2 Global Radiopharmaceutical Sales by Region (2025-2030)
6.3 Global Radiopharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Radiopharmaceutical Sales Value by Region (2019-2030)
6.4.1 Global Radiopharmaceutical Sales Value by Region: 2019-2024
6.4.2 Global Radiopharmaceutical Sales Value by Region (2025-2030)
6.5 Global Radiopharmaceutical Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Radiopharmaceutical Sales Value (2019-2030)
6.6.2 North America Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Radiopharmaceutical Sales Value (2019-2030)
6.7.2 Europe Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Radiopharmaceutical Sales Value (2019-2030)
6.8.2 Asia-Pacific Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Radiopharmaceutical Sales Value (2019-2030)
6.9.2 Latin America Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Radiopharmaceutical Sales Value (2019-2030)
6.10.2 Middle East & Africa Radiopharmaceutical Sales Value Share by Country, 2023 VS 2030
7 RADIOPHARMACEUTICAL MARKET BY COUNTRY
7.1 Global Radiopharmaceutical Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Radiopharmaceutical Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Radiopharmaceutical Sales by Country (2019-2030)
7.3.1 Global Radiopharmaceutical Sales by Country (2019-2024)
7.3.2 Global Radiopharmaceutical Sales by Country (2025-2030)
7.4 Global Radiopharmaceutical Sales Value by Country (2019-2030)
7.4.1 Global Radiopharmaceutical Sales Value by Country (2019-2024)
7.4.2 Global Radiopharmaceutical Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.5.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.6.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.7.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.8.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.9.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.10.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.11.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.12.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.13.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.14.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.15.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.16.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.17.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.18.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.19.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.20.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.21.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.22.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Radiopharmaceutical Sales Value Growth Rate (2019-2030)
7.23.2 Global Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Bracco Imaging
8.1.1 Bracco Imaging Comapny Information
8.1.2 Bracco Imaging Business Overview
8.1.3 Bracco Imaging Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
8.1.5 Bracco Imaging Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.2.4 Bayer Radiopharmaceutical Product Portfolio
8.2.5 Bayer Recent Developments
8.3 Mallinckrodt
8.3.1 Mallinckrodt Comapny Information
8.3.2 Mallinckrodt Business Overview
8.3.3 Mallinckrodt Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
8.3.5 Mallinckrodt Recent Developments
8.4 Nordion
8.4.1 Nordion Comapny Information
8.4.2 Nordion Business Overview
8.4.3 Nordion Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.4.4 Nordion Radiopharmaceutical Product Portfolio
8.4.5 Nordion Recent Developments
8.5 Triad Isotopes
8.5.1 Triad Isotopes Comapny Information
8.5.2 Triad Isotopes Business Overview
8.5.3 Triad Isotopes Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
8.5.5 Triad Isotopes Recent Developments
8.6 Lantheus
8.6.1 Lantheus Comapny Information
8.6.2 Lantheus Business Overview
8.6.3 Lantheus Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.6.4 Lantheus Radiopharmaceutical Product Portfolio
8.6.5 Lantheus Recent Developments
8.7 IBA Group
8.7.1 IBA Group Comapny Information
8.7.2 IBA Group Business Overview
8.7.3 IBA Group Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.7.4 IBA Group Radiopharmaceutical Product Portfolio
8.7.5 IBA Group Recent Developments
8.8 GE Healthcare
8.8.1 GE Healthcare Comapny Information
8.8.2 GE Healthcare Business Overview
8.8.3 GE Healthcare Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
8.8.5 GE Healthcare Recent Developments
8.9 China Isotope & Radiation
8.9.1 China Isotope & Radiation Comapny Information
8.9.2 China Isotope & Radiation Business Overview
8.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
8.9.5 China Isotope & Radiation Recent Developments
8.10 Jubilant Pharma
8.10.1 Jubilant Pharma Comapny Information
8.10.2 Jubilant Pharma Business Overview
8.10.3 Jubilant Pharma Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
8.10.5 Jubilant Pharma Recent Developments
8.11 Eli Lilly
8.11.1 Eli Lilly Comapny Information
8.11.2 Eli Lilly Business Overview
8.11.3 Eli Lilly Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
8.11.5 Eli Lilly Recent Developments
8.12 Advanced Accelerator Applications
8.12.1 Advanced Accelerator Applications Comapny Information
8.12.2 Advanced Accelerator Applications Business Overview
8.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
8.12.5 Advanced Accelerator Applications Recent Developments
8.13 SIEMENS
8.13.1 SIEMENS Comapny Information
8.13.2 SIEMENS Business Overview
8.13.3 SIEMENS Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.13.4 SIEMENS Radiopharmaceutical Product Portfolio
8.13.5 SIEMENS Recent Developments
8.14 Dongcheng
8.14.1 Dongcheng Comapny Information
8.14.2 Dongcheng Business Overview
8.14.3 Dongcheng Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.14.4 Dongcheng Radiopharmaceutical Product Portfolio
8.14.5 Dongcheng Recent Developments
8.15 Navidea
8.15.1 Navidea Comapny Information
8.15.2 Navidea Business Overview
8.15.3 Navidea Radiopharmaceutical Sales, Value and Gross Margin (2019-2024)
8.15.4 Navidea Radiopharmaceutical Product Portfolio
8.15.5 Navidea Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Radiopharmaceutical Value Chain Analysis
9.1.1 Radiopharmaceutical Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Radiopharmaceutical Sales Mode & Process
9.2 Radiopharmaceutical Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Radiopharmaceutical Distributors
9.2.3 Radiopharmaceutical Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Radiopharmaceutical Industry Trends
Table 2. Radiopharmaceutical Industry Drivers
Table 3. Radiopharmaceutical Industry Opportunities and Challenges
Table 4. Radiopharmaceutical Industry Restraints
Table 5. Global Radiopharmaceutical Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Radiopharmaceutical Revenue Share by Company (2019-2024)
Table 7. Global Radiopharmaceutical Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Radiopharmaceutical Sales Volume Share by Company (2019-2024)
Table 9. Global Radiopharmaceutical Average Price (USD/Dose) of Company (2019-2024)
Table 10. Global Radiopharmaceutical Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Radiopharmaceutical Key Company Manufacturing Base & Headquarters
Table 12. Global Radiopharmaceutical Company, Product Type & Application
Table 13. Global Radiopharmaceutical Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Actinium-225
Table 18. Major Companies of Lutetium-177
Table 19. Major Companies of Radium-223
Table 20. Major Companies of Holmium-166
Table 21. Major Companies of Other
Table 22. Global Radiopharmaceutical Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 23. Global Radiopharmaceutical Sales Volume by Type (2019-2024) & (M Doses)
Table 24. Global Radiopharmaceutical Sales Volume by Type (2025-2030) & (M Doses)
Table 25. Global Radiopharmaceutical Sales Volume Share by Type (2019-2024)
Table 26. Global Radiopharmaceutical Sales Volume Share by Type (2025-2030)
Table 27. Global Radiopharmaceutical Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Radiopharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 29. Global Radiopharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 30. Global Radiopharmaceutical Sales Value Share by Type (2019-2024)
Table 31. Global Radiopharmaceutical Sales Value Share by Type (2025-2030)
Table 32. Major Companies of Oncology
Table 33. Major Companies of Cardiology
Table 34. Major Companies of Other
Table 35. Global Radiopharmaceutical Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Radiopharmaceutical Sales Volume by Application (2019-2024) & (M Doses)
Table 37. Global Radiopharmaceutical Sales Volume by Application (2025-2030) & (M Doses)
Table 38. Global Radiopharmaceutical Sales Volume Share by Application (2019-2024)
Table 39. Global Radiopharmaceutical Sales Volume Share by Application (2025-2030)
Table 40. Global Radiopharmaceutical Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Radiopharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 42. Global Radiopharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 43. Global Radiopharmaceutical Sales Value Share by Application (2019-2024)
Table 44. Global Radiopharmaceutical Sales Value Share by Application (2025-2030)
Table 45. Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 46. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 47. Global Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 48. Global Radiopharmaceutical Sales by Region (2025-2030) & (M Doses)
Table 49. Global Radiopharmaceutical Sales Market Share by Region (2025-2030)
Table 50. Global Radiopharmaceutical Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 51. Global Radiopharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 52. Global Radiopharmaceutical Sales Value Share by Region (2019-2024)
Table 53. Global Radiopharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 54. Global Radiopharmaceutical Sales Value Share by Region (2025-2030)
Table 55. Global Radiopharmaceutical Market Average Price (USD/Dose) by Region (2019-2024)
Table 56. Global Radiopharmaceutical Market Average Price (USD/Dose) by Region (2025-2030)
Table 57. Global Radiopharmaceutical Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 58. Global Radiopharmaceutical Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 60. Global Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 61. Global Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 62. Global Radiopharmaceutical Sales Market Share by Country (2025-2030)
Table 63. Global Radiopharmaceutical Sales Value by Country (2019-2024) & (US$ Million)
Table 64. Global Radiopharmaceutical Sales Value Market Share by Country (2019-2024)
Table 65. Global Radiopharmaceutical Sales Value by Country (2025-2030) & (US$ Million)
Table 66. Global Radiopharmaceutical Sales Value Market Share by Country (2025-2030)
Table 67. Bracco Imaging Company Information
Table 68. Bracco Imaging Business Overview
Table 69. Bracco Imaging Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 70. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 71. Bracco Imaging Recent Development
Table 72. Bayer Company Information
Table 73. Bayer Business Overview
Table 74. Bayer Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 75. Bayer Radiopharmaceutical Product Portfolio
Table 76. Bayer Recent Development
Table 77. Mallinckrodt Company Information
Table 78. Mallinckrodt Business Overview
Table 79. Mallinckrodt Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 80. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 81. Mallinckrodt Recent Development
Table 82. Nordion Company Information
Table 83. Nordion Business Overview
Table 84. Nordion Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 85. Nordion Radiopharmaceutical Product Portfolio
Table 86. Nordion Recent Development
Table 87. Triad Isotopes Company Information
Table 88. Triad Isotopes Business Overview
Table 89. Triad Isotopes Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 90. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 91. Triad Isotopes Recent Development
Table 92. Lantheus Company Information
Table 93. Lantheus Business Overview
Table 94. Lantheus Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 95. Lantheus Radiopharmaceutical Product Portfolio
Table 96. Lantheus Recent Development
Table 97. IBA Group Company Information
Table 98. IBA Group Business Overview
Table 99. IBA Group Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 100. IBA Group Radiopharmaceutical Product Portfolio
Table 101. IBA Group Recent Development
Table 102. GE Healthcare Company Information
Table 103. GE Healthcare Business Overview
Table 104. GE Healthcare Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 105. GE Healthcare Radiopharmaceutical Product Portfolio
Table 106. GE Healthcare Recent Development
Table 107. China Isotope & Radiation Company Information
Table 108. China Isotope & Radiation Business Overview
Table 109. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 110. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 111. China Isotope & Radiation Recent Development
Table 112. Jubilant Pharma Company Information
Table 113. Jubilant Pharma Business Overview
Table 114. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 115. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 116. Jubilant Pharma Recent Development
Table 117. Eli Lilly Company Information
Table 118. Eli Lilly Business Overview
Table 119. Eli Lilly Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 120. Eli Lilly Radiopharmaceutical Product Portfolio
Table 121. Eli Lilly Recent Development
Table 122. Advanced Accelerator Applications Company Information
Table 123. Advanced Accelerator Applications Business Overview
Table 124. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 125. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 126. Advanced Accelerator Applications Recent Development
Table 127. SIEMENS Company Information
Table 128. SIEMENS Business Overview
Table 129. SIEMENS Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 130. SIEMENS Radiopharmaceutical Product Portfolio
Table 131. SIEMENS Recent Development
Table 132. Dongcheng Company Information
Table 133. Dongcheng Business Overview
Table 134. Dongcheng Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 135. Dongcheng Radiopharmaceutical Product Portfolio
Table 136. Dongcheng Recent Development
Table 137. Navidea Company Information
Table 138. Navidea Business Overview
Table 139. Navidea Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 140. Navidea Radiopharmaceutical Product Portfolio
Table 141. Navidea Recent Development
Table 142. Key Raw Materials
Table 143. Raw Materials Key Suppliers
Table 144. Radiopharmaceutical Distributors List
Table 145. Radiopharmaceutical Customers List
Table 146. Research Programs/Design for This Report
Table 147. Authors List of This Report
Table 148. Secondary Sources
Table 149. Primary Sources
Table 1. Radiopharmaceutical Industry Trends
Table 2. Radiopharmaceutical Industry Drivers
Table 3. Radiopharmaceutical Industry Opportunities and Challenges
Table 4. Radiopharmaceutical Industry Restraints
Table 5. Global Radiopharmaceutical Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Radiopharmaceutical Revenue Share by Company (2019-2024)
Table 7. Global Radiopharmaceutical Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Radiopharmaceutical Sales Volume Share by Company (2019-2024)
Table 9. Global Radiopharmaceutical Average Price (USD/Dose) of Company (2019-2024)
Table 10. Global Radiopharmaceutical Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Radiopharmaceutical Key Company Manufacturing Base & Headquarters
Table 12. Global Radiopharmaceutical Company, Product Type & Application
Table 13. Global Radiopharmaceutical Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Actinium-225
Table 18. Major Companies of Lutetium-177
Table 19. Major Companies of Radium-223
Table 20. Major Companies of Holmium-166
Table 21. Major Companies of Other
Table 22. Global Radiopharmaceutical Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 23. Global Radiopharmaceutical Sales Volume by Type (2019-2024) & (M Doses)
Table 24. Global Radiopharmaceutical Sales Volume by Type (2025-2030) & (M Doses)
Table 25. Global Radiopharmaceutical Sales Volume Share by Type (2019-2024)
Table 26. Global Radiopharmaceutical Sales Volume Share by Type (2025-2030)
Table 27. Global Radiopharmaceutical Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Radiopharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 29. Global Radiopharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 30. Global Radiopharmaceutical Sales Value Share by Type (2019-2024)
Table 31. Global Radiopharmaceutical Sales Value Share by Type (2025-2030)
Table 32. Major Companies of Oncology
Table 33. Major Companies of Cardiology
Table 34. Major Companies of Other
Table 35. Global Radiopharmaceutical Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Radiopharmaceutical Sales Volume by Application (2019-2024) & (M Doses)
Table 37. Global Radiopharmaceutical Sales Volume by Application (2025-2030) & (M Doses)
Table 38. Global Radiopharmaceutical Sales Volume Share by Application (2019-2024)
Table 39. Global Radiopharmaceutical Sales Volume Share by Application (2025-2030)
Table 40. Global Radiopharmaceutical Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Radiopharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 42. Global Radiopharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 43. Global Radiopharmaceutical Sales Value Share by Application (2019-2024)
Table 44. Global Radiopharmaceutical Sales Value Share by Application (2025-2030)
Table 45. Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 46. Global Radiopharmaceutical Sales by Region (2019-2024) & (M Doses)
Table 47. Global Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 48. Global Radiopharmaceutical Sales by Region (2025-2030) & (M Doses)
Table 49. Global Radiopharmaceutical Sales Market Share by Region (2025-2030)
Table 50. Global Radiopharmaceutical Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 51. Global Radiopharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 52. Global Radiopharmaceutical Sales Value Share by Region (2019-2024)
Table 53. Global Radiopharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 54. Global Radiopharmaceutical Sales Value Share by Region (2025-2030)
Table 55. Global Radiopharmaceutical Market Average Price (USD/Dose) by Region (2019-2024)
Table 56. Global Radiopharmaceutical Market Average Price (USD/Dose) by Region (2025-2030)
Table 57. Global Radiopharmaceutical Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 58. Global Radiopharmaceutical Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Radiopharmaceutical Sales by Country (2019-2024) & (M Doses)
Table 60. Global Radiopharmaceutical Sales Market Share by Country (2019-2024)
Table 61. Global Radiopharmaceutical Sales by Country (2025-2030) & (M Doses)
Table 62. Global Radiopharmaceutical Sales Market Share by Country (2025-2030)
Table 63. Global Radiopharmaceutical Sales Value by Country (2019-2024) & (US$ Million)
Table 64. Global Radiopharmaceutical Sales Value Market Share by Country (2019-2024)
Table 65. Global Radiopharmaceutical Sales Value by Country (2025-2030) & (US$ Million)
Table 66. Global Radiopharmaceutical Sales Value Market Share by Country (2025-2030)
Table 67. Bracco Imaging Company Information
Table 68. Bracco Imaging Business Overview
Table 69. Bracco Imaging Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 70. Bracco Imaging Radiopharmaceutical Product Portfolio
Table 71. Bracco Imaging Recent Development
Table 72. Bayer Company Information
Table 73. Bayer Business Overview
Table 74. Bayer Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 75. Bayer Radiopharmaceutical Product Portfolio
Table 76. Bayer Recent Development
Table 77. Mallinckrodt Company Information
Table 78. Mallinckrodt Business Overview
Table 79. Mallinckrodt Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 80. Mallinckrodt Radiopharmaceutical Product Portfolio
Table 81. Mallinckrodt Recent Development
Table 82. Nordion Company Information
Table 83. Nordion Business Overview
Table 84. Nordion Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 85. Nordion Radiopharmaceutical Product Portfolio
Table 86. Nordion Recent Development
Table 87. Triad Isotopes Company Information
Table 88. Triad Isotopes Business Overview
Table 89. Triad Isotopes Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 90. Triad Isotopes Radiopharmaceutical Product Portfolio
Table 91. Triad Isotopes Recent Development
Table 92. Lantheus Company Information
Table 93. Lantheus Business Overview
Table 94. Lantheus Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 95. Lantheus Radiopharmaceutical Product Portfolio
Table 96. Lantheus Recent Development
Table 97. IBA Group Company Information
Table 98. IBA Group Business Overview
Table 99. IBA Group Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 100. IBA Group Radiopharmaceutical Product Portfolio
Table 101. IBA Group Recent Development
Table 102. GE Healthcare Company Information
Table 103. GE Healthcare Business Overview
Table 104. GE Healthcare Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 105. GE Healthcare Radiopharmaceutical Product Portfolio
Table 106. GE Healthcare Recent Development
Table 107. China Isotope & Radiation Company Information
Table 108. China Isotope & Radiation Business Overview
Table 109. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 110. China Isotope & Radiation Radiopharmaceutical Product Portfolio
Table 111. China Isotope & Radiation Recent Development
Table 112. Jubilant Pharma Company Information
Table 113. Jubilant Pharma Business Overview
Table 114. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 115. Jubilant Pharma Radiopharmaceutical Product Portfolio
Table 116. Jubilant Pharma Recent Development
Table 117. Eli Lilly Company Information
Table 118. Eli Lilly Business Overview
Table 119. Eli Lilly Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 120. Eli Lilly Radiopharmaceutical Product Portfolio
Table 121. Eli Lilly Recent Development
Table 122. Advanced Accelerator Applications Company Information
Table 123. Advanced Accelerator Applications Business Overview
Table 124. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 125. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
Table 126. Advanced Accelerator Applications Recent Development
Table 127. SIEMENS Company Information
Table 128. SIEMENS Business Overview
Table 129. SIEMENS Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 130. SIEMENS Radiopharmaceutical Product Portfolio
Table 131. SIEMENS Recent Development
Table 132. Dongcheng Company Information
Table 133. Dongcheng Business Overview
Table 134. Dongcheng Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 135. Dongcheng Radiopharmaceutical Product Portfolio
Table 136. Dongcheng Recent Development
Table 137. Navidea Company Information
Table 138. Navidea Business Overview
Table 139. Navidea Radiopharmaceutical Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 140. Navidea Radiopharmaceutical Product Portfolio
Table 141. Navidea Recent Development
Table 142. Key Raw Materials
Table 143. Raw Materials Key Suppliers
Table 144. Radiopharmaceutical Distributors List
Table 145. Radiopharmaceutical Customers List
Table 146. Research Programs/Design for This Report
Table 147. Authors List of This Report
Table 148. Secondary Sources
Table 149. Primary Sources
LIST OF FIGURES
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Radiopharmaceutical Sales (2019-2030) & (M Doses)
Figure 5. Global Radiopharmaceutical Sales Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Radiopharmaceutical Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Actinium-225 Picture
Figure 10. Lutetium-177 Picture
Figure 11. Radium-223 Picture
Figure 12. Holmium-166 Picture
Figure 13. Other Picture
Figure 14. Global Radiopharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 15. Global Radiopharmaceutical Sales Volume Share 2019 VS 2023 VS 2030
Figure 16. Global Radiopharmaceutical Sales Volume Share by Type (2019-2030)
Figure 17. Global Radiopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Radiopharmaceutical Sales Value Share 2019 VS 2023 VS 2030
Figure 19. Global Radiopharmaceutical Sales Value Share by Type (2019-2030)
Figure 20. Oncology Picture
Figure 21. Cardiology Picture
Figure 22. Other Picture
Figure 23. Global Radiopharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 24. Global Radiopharmaceutical Sales Volume Share 2019 VS 2023 VS 2030
Figure 25. Global Radiopharmaceutical Sales Volume Share by Application (2019-2030)
Figure 26. Global Radiopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Radiopharmaceutical Sales Value Share 2019 VS 2023 VS 2030
Figure 28. Global Radiopharmaceutical Sales Value Share by Application (2019-2030)
Figure 29. Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 30. Global Radiopharmaceutical Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. Global Radiopharmaceutical Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 32. Global Radiopharmaceutical Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 33. North America Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 34. North America Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Europe Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 36. Europe Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Asia-Pacific Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 39. Latin America Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 40. Latin America Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 41. Middle East & Africa Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 43. USA Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. USA Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. USA Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Canada Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Canada Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Canada Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Germany Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Germany Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. Germany Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. France Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. France Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. France Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. U.K. Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.K. Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. U.K. Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Italy Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Italy Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Italy Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Netherlands Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Netherlands Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Netherlands Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. Nordic Countries Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. Nordic Countries Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. Nordic Countries Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. China Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. China Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. China Radiopharmaceutical Sales Value Share by Applicatio
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Radiopharmaceutical Sales (2019-2030) & (M Doses)
Figure 5. Global Radiopharmaceutical Sales Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Radiopharmaceutical Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Actinium-225 Picture
Figure 10. Lutetium-177 Picture
Figure 11. Radium-223 Picture
Figure 12. Holmium-166 Picture
Figure 13. Other Picture
Figure 14. Global Radiopharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 15. Global Radiopharmaceutical Sales Volume Share 2019 VS 2023 VS 2030
Figure 16. Global Radiopharmaceutical Sales Volume Share by Type (2019-2030)
Figure 17. Global Radiopharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Radiopharmaceutical Sales Value Share 2019 VS 2023 VS 2030
Figure 19. Global Radiopharmaceutical Sales Value Share by Type (2019-2030)
Figure 20. Oncology Picture
Figure 21. Cardiology Picture
Figure 22. Other Picture
Figure 23. Global Radiopharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 24. Global Radiopharmaceutical Sales Volume Share 2019 VS 2023 VS 2030
Figure 25. Global Radiopharmaceutical Sales Volume Share by Application (2019-2030)
Figure 26. Global Radiopharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Radiopharmaceutical Sales Value Share 2019 VS 2023 VS 2030
Figure 28. Global Radiopharmaceutical Sales Value Share by Application (2019-2030)
Figure 29. Global Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 30. Global Radiopharmaceutical Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. Global Radiopharmaceutical Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 32. Global Radiopharmaceutical Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 33. North America Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 34. North America Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Europe Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 36. Europe Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Asia-Pacific Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 39. Latin America Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 40. Latin America Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 41. Middle East & Africa Radiopharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Radiopharmaceutical Sales Value Share by Country (%), 2023 VS 2030
Figure 43. USA Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. USA Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. USA Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Canada Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Canada Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Canada Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Germany Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Germany Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. Germany Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. France Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. France Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. France Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. U.K. Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.K. Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. U.K. Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Italy Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Italy Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Italy Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Netherlands Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Netherlands Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Netherlands Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. Nordic Countries Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. Nordic Countries Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. Nordic Countries Radiopharmaceutical Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. China Radiopharmaceutical Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. China Radiopharmaceutical Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. China Radiopharmaceutical Sales Value Share by Applicatio
